Sign inJoin waitlistJoin the waitlist

LM

Laszlo Mechtler

Physician · Dent Neurologic Group Llp

Credentials: · · ·

History

Dent Neurologic Group Llp · Roswell Park Comprehensive Cancer Center
Present

University of Texas M D Anderson Cancer Center
1989–1990
Neurology
1985–1989
Doctor of Medicine
1980–1984

Research

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
The Lancet Oncology · 2017 · 932 citations
Non-Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study
Headache · 2016 · 188 citations
A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma
Neuro-Oncology · 2003 · 164 citations

PK
Peter Kinkel
12 papers
Rohit Bakshi
12 papers · 10 as a fellow
VB
Vernice Bates
11 papers
WK
William Kinkel
9 papers
JM
Jennifer McVige
6 papers
NP
Nandor Pinter
6 papers
Rebecca Cornelius
5 papers
Robert Fenstermaker
5 papers
FW
Franz Wippold
4 papers
CM
Charles Mcconnell
3 papers
Christopher Roth
3 papers · 1 as a fellow
DS
David Seidenwurm
3 papers

Clinical trials

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines
Principal investigator · Completed · Phase 2
Dent Neuroscience Research Center
2013–2015
Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
Principal investigator · Unknown
Dent Neurologic Institute
2010–2015
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2026–2028
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2023–2028